223 related articles for article (PubMed ID: 11827633)
1. Aortic valve sclerosis as a marker of active atherosclerosis.
Branch KR; O'Brien KD; Otto CM
Curr Cardiol Rep; 2002 Mar; 4(2):111-7. PubMed ID: 11827633
[TBL] [Abstract][Full Text] [Related]
2. [Calcific aortic valve stenosis: degeneration or atherosclerosis?].
Kaden JJ; Haase KK; Borggrefe M
Dtsch Med Wochenschr; 2001 Apr; 126(14):405-7. PubMed ID: 11332244
[No Abstract] [Full Text] [Related]
3. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study.
Stewart BF; Siscovick D; Lind BK; Gardin JM; Gottdiener JS; Smith VE; Kitzman DW; Otto CM
J Am Coll Cardiol; 1997 Mar; 29(3):630-4. PubMed ID: 9060903
[TBL] [Abstract][Full Text] [Related]
4. Association of aortic valve sclerosis and coronary artery disease in patients with severe nonischemic mitral regurgitation.
Rossi A; Bertagnolli G; Cicoira M; Golia G; Zanolla L; Santini F; Cemin C; Ferrario G; Zardini P
Clin Cardiol; 2003 Dec; 26(12):579-82. PubMed ID: 14677812
[TBL] [Abstract][Full Text] [Related]
5. Aortic sclerosis: not an innocent murmur but a marker of increased cardiovascular risk.
Nightingale AK; Horowitz JD
Heart; 2005 Nov; 91(11):1389-93. PubMed ID: 15797932
[TBL] [Abstract][Full Text] [Related]
6. Pathology of calcific aortic stenosis.
Ladich E; Nakano M; Carter-Monroe N; Virmani R
Future Cardiol; 2011 Sep; 7(5):629-42. PubMed ID: 21929343
[TBL] [Abstract][Full Text] [Related]
7. Aortic sclerosis--a marker of coronary atherosclerosis.
Prasad Y; Bhalodkar NC
Clin Cardiol; 2004 Dec; 27(12):671-3. PubMed ID: 15628107
[TBL] [Abstract][Full Text] [Related]
8. Determinants of occurrence of aortic sclerosis in an aging population.
Ngo DT; Sverdlov AL; Willoughby SR; Nightingale AK; Chirkov YY; McNeil JJ; Horowitz JD
JACC Cardiovasc Imaging; 2009 Aug; 2(8):919-27. PubMed ID: 19679278
[TBL] [Abstract][Full Text] [Related]
9. Identification of tissue factor in experimental aortic valve sclerosis.
Marechaux S; Corseaux D; Vincentelli A; Richardson M; Ung A; Susen S; Zawadzki C; Beregi JP; Ezekowitz MD; Jude B; Le Tourneau T
Cardiovasc Pathol; 2009; 18(2):67-76. PubMed ID: 18402835
[TBL] [Abstract][Full Text] [Related]
10. A case of familial calcific aortic and mitral stenosis in association with hereditary sclerosing poikiloderma.
DeMaria D; Mejia-Lopez E; Kelting SM; Soukoulis V
Cardiovasc Pathol; 2016; 25(3):195-199. PubMed ID: 26874040
[TBL] [Abstract][Full Text] [Related]
11. Current Evidence and Future Perspectives on Pharmacological Treatment of Calcific Aortic Valve Stenosis.
Donato M; Ferri N; Lupo MG; Faggin E; Rattazzi M
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33158204
[TBL] [Abstract][Full Text] [Related]
12. Sex-Specific Features of Calcific Aortic Valve Disease.
Summerhill VI; Moschetta D; Orekhov AN; Poggio P; Myasoedova VA
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32781508
[TBL] [Abstract][Full Text] [Related]
13. Targeting vasoactive peptides for managing calcific aortic valve disease.
Peltonen T; Ohukainen P; Ruskoaho H; Rysä J
Ann Med; 2017 Feb; 49(1):63-74. PubMed ID: 27585243
[TBL] [Abstract][Full Text] [Related]
14. Mitral and aortic valve sclerosis/calcification and carotid atherosclerosis: results from 1065 patients.
Rossi A; Faggiano P; Amado AE; Cicoira M; Bonapace S; Franceschini L; Dini FL; Ghio S; Agricola E; Temporelli PL; Vassanelli C
Heart Vessels; 2014 Nov; 29(6):776-83. PubMed ID: 24196525
[TBL] [Abstract][Full Text] [Related]
15. Are atherosclerotic processes involved in aortic-valve calcification?
Mohler ER
Lancet; 2000 Aug; 356(9229):524-5. PubMed ID: 10950224
[No Abstract] [Full Text] [Related]
16. Values of osteoprotegerin in aortic valve tissue in patients with significant aortic stenosis depend on the existence of concomitant coronary artery disease.
Fojt R; Pirk J; Kamenický P; Karpíšek M; Straka Z; Malý M; Moťovská Z
Cardiovasc Pathol; 2016; 25(3):181-184. PubMed ID: 26874038
[TBL] [Abstract][Full Text] [Related]
17. Targeted therapy to prevent progression of calcific aortic stenosis.
Rajamannan NM; Otto CM
Circulation; 2004 Sep; 110(10):1180-2. PubMed ID: 15353511
[No Abstract] [Full Text] [Related]
18. [Can we prevent the progression of aortic valve sclerosis and stenosis? The need for a prospective, randomized trial].
Scardi S; Cherubini A
Ital Heart J Suppl; 2005 Jul; 6(7):403-12. PubMed ID: 16082823
[TBL] [Abstract][Full Text] [Related]
19. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies.
Freeman RV; Otto CM
Circulation; 2005 Jun; 111(24):3316-26. PubMed ID: 15967862
[No Abstract] [Full Text] [Related]
20. Clinical factors, but not C-reactive protein, predict progression of calcific aortic-valve disease: the Cardiovascular Health Study.
Novaro GM; Katz R; Aviles RJ; Gottdiener JS; Cushman M; Psaty BM; Otto CM; Griffin BP
J Am Coll Cardiol; 2007 Nov; 50(20):1992-8. PubMed ID: 17996566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
